Menu
Menu
Dear Editor: Winkelmann et al[1] presented evidence on the usefulness of multispectral digital skin lesion analysis (MelaFind®; MELA Sciences, Inc.) as an aid in evaluating pigmented lesions (PLs) that have
aJames H. Herndon, Jr, MD, FAAD; bElizabeth T. Makino, BS, CCRA, MBA; aLily I. Jiang, PhD; aThomas J. Stephens, PhD; bRahul C. Mehta, PhD aThomas J. Stephens & Associates, Richardson,
Guy Webster, MD, PhD Department of Dermatology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania Disclosure: Dr. Webster is a consultant for Janssen, Galderma, and Valeant. Abstract
aAnna D. Holmes, PhD; aKimberly A. Waite, BS; aMichael C. Chen, PhD; aKiruthi Palaniswamy, PharmD; aThomas H. Wiser, PharmD; bZoe D. Draelos, MD; cElyse S. Rafal, MD; dW. Philip Werschler,
aJoshua P. Fogelman, MD; bMary L. Stevenson, MD; b,cRobin Ashinoff, MD; bNicholas A. Soter, MD aDepartment of Dermatology, Columbia University, and Dermatology Center of Rockland, P.C., New York, New York,
aIrene Tausch, MD; IlJa Kruglikov, PhD, DrSci aKosmed Clinic, Kiel, Germany; bWellcomet GmbH, Karlsruhe, Germany Disclosure: Dr. Tausch reports no relevant conflicts of interest. Dr. Kruglikov is the managing partner
aReza Yaghoobi, MD; bAbdolhasan Talaizade, MD; cKaran Lal, BS; dNastaran Ranjbari, MD; aNasibe Sohrabiaan, MD; eAmir Feily, MD aDepartment of Dermatology, Jundishapur University of Medical Sciences, Ahvaz, Iran; bDeparment of
aStephanie Feldstein, MD; bSmita Awasthi, MD; aAndrew C. Krakowski, MD aRady Children’s Hospital, San Diego, California and University of California, San Diego; bDepartment of Dermatology, University of California-Davis, Sacramento, California
